Skip to main content
. Author manuscript; available in PMC: 2021 Dec 27.
Published in final edited form as: Free Radic Biol Med. 2021 Jun 25;172:490–502. doi: 10.1016/j.freeradbiomed.2021.06.024

Table 1.

Demographic, clinical and histological characteristics of study subjects.

Hispanics Caucasians p-value
NAFL HC NAFL HC a b c
Liver, n (F/M) 7 (5/2) - 10 (5/5) -
Plasma, n (F/M) 7 (5/2) 14 (6/8) 8 (4/4) 8 (4/4)
 Age (Yrs.) 45 ± 16 43 ± 14 50 ± 16 44 ± 12 0.818 0.413 0.55
 BMI (Kg/m2) 47 ± 7 26 ± 2 42 ± 7 25 ± 3 <.0001 <.0001 0.28
 DM, yes (%) 3 (42.9) - 4 (40) - - - 0.913
 FBG mmol/L 93 ± 5 - 94 ± 13 - - - 0.88
 Cholesterol (mg/dL) 168 ± 29 - 173 ± 33 - - - 0.952
 TG (mg/dL) 112 ± 37 - 139 ± 65 - - - 0.42
 HDL (mg/dL) 44 ± 7 - 41 ± 8 - - - 0.403
 LDL (mg/dL) 102 ± 23 - 104 ± 33 - - - 0.855
 HbA1c (%) 6.1 ± 0.7 - 6.2 ± 0.8 - - - 0.67
 AST (U/L) 27 ± 12 - 31 ± 19 - - - 0.499
 ALT (U/L) 34 ± 18 - 31 ± 10 - - - 0.752
 Platelet 308 ± 58 - 292 ± 100 - - - 0.506
 NAS 2.43 ± 2.40 - 3 ± 1.5 - - - 0.653
 NASH, yes (%) 6 (60) - 5 (50) - - - 0.708
Steatosis (%)
 < 5% 3 (42.8) - 2 (20) - - - 0.452
 5 to ≤ 33% 2 (28.6) - 5 (50) - - -
 34 to ≤ 66 % 2 (28.6) - 2 (20) - - -
 > 66% 0 (0) - 1 (10) - - -
Inflammation (%)
 None 3 (42.9) - 1 (10) - - - 0.763
 Mild 1 (14.3) - 6 (60) - - -
 Moderate 2 (28.6) - 3 (30) - - -
 Severe 1 (14.3) - 0 (0) - - -
Ballooning (%)
 None 4 (57) - 5 (50) - - - 0.772
 Few 3 (42.9) - 5 (50) - - -
 Many 0 (0) - 0 (0) - - -
Fibrosis (%)
 None 7 (100) - 9 (90) - - - 0.998
 1A 0 (0) - 1 (10) - - -
 2 0 (0) - 0 (0) - - -
 4 0 (0) - 0 (0) - - -

General characteristics are shown as percent (for categorical data) and mean ± SEM (for nominal data). Group comparisons were performed by chi-square test (categorical) or t- test (nominal). (a) NAFL-HIS vs. HC-HIS; (b) NAFL-CAU vs. HC-CAU; (c) NAFL-HIS vs. NAFL-CAU. ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; DM, diabetes mellitus; FBG, fasting blood glucose; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low density lipoprotein; NAS, the NAFLD Activity Score; TG, triglycerides.